Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension

Free Subscription 29.06.2026 1 Afr J Thorac Crit Care Med 1 Arch Biochem Biophys 1 Arterioscler Thromb Vasc Biol 1 Arthritis Res Ther 1 Biomedicines 1 bioRxiv 1 BMC Cardiovasc Disord 1 BMC Med Imaging 2 BMC Nephrol 3 BMC Pulm Med 1 Cardiol Discov 1 Cardiol Rev 1 Cardiovasc J Afr 1 CJC Open 1 Climacteric 1 Clin Ter 1 Commun Biol 1 EJNMMI Res 1 Eur J Appl Physiol 1 Expert Rev Clin Pharmacol 1 Expert Rev Respir Med 1 Front Immunol 1 Healthcare (Basel) 1 Indian Heart J 1 Indian J Radiol Imaging 1 Int J Cardiol Heart Vasc 1 Int J Med Sci 1 Int J Mol Sci 2 J Cardiovasc Dev Dis 1 J Clin Med 1 J Clin Rheumatol 1 J Mol Cell Cardiol 1 J Nanobiotechnology 1 JACC Cardiovasc Imaging 1 Med Sci (Basel) 1 Medicina (B Aires) 1 Medicina (Kaunas) 1 medRxiv 1 Paediatr Respir Rev 1 Pediatr Pulmonol 1 PLoS One 1 Pulm Circ 1 Respir Investig 1 Respir Med 2 Respir Res 1 Rev Med Interne 1 SAGE Open Med 1 Sci Prog 1 Toxicol Sci 1 Transl Vis Sci Technol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Afr J Thorac Crit Care Med

1. PERUMAL R
   Catalysing future research on the under-recognised burden of post-tuberculosis pulmonary hypertension.
   Afr J Thorac Crit Care Med. 2026;32:e4992.
   PubMed        
   
   

   
   Arch Biochem Biophys

2. BAI P, Wu Z, Qiao Y, Nie X, et al
   Sitosterol-Beta mitigates pulmonary hypertension by targeting SPHK1 in mice.
   Arch Biochem Biophys. 2026 Jun 24:110913. doi: 10.1016/j.abb.2026.110913.
   PubMed         Abstract available
   
   

   
   Arterioscler Thromb Vasc Biol

3. PANG J, Li S, Wang G, Abe JI, et al
   Interpreting Pulmonary Hypertension Beyond Single Cells.
   Arterioscler Thromb Vasc Biol. 2026 Jun 25. doi: 10.1161/ATVBAHA.126.324960.
   PubMed        
   
   

   
   Arthritis Res Ther

4. BOLETO G, Cauvet A, Guignabert C, Thuillet R, et al
   Soquelitinib inhibition of IL-2-inducible T cell kinase ameliorates lung damage in murine models of systemic sclerosis.
   Arthritis Res Ther. 2025;27:228.
   PubMed         Abstract available
   
   

   
   Biomedicines

5. WSZELAKI P, Karczmarska A, Szymoniuk S, Grzesk G, et al
   The Role of Platelets in Pulmonary Hypertension: From Activation to Pulmonary Vascular Remodeling-A Review Article.
   Biomedicines. 2026;14:1203.
   PubMed         Abstract available
   
   

   
   bioRxiv

6. LOYA O, Villarreal ES, Carneiro A, Agarwal S, et al
   Sex-linked Lung Estrobolome May Contribute to Pulmonary Hypertension Penetrance of Bmpr2 R899X Mutation via an ET-1 (high) Endoregulatory Macrophage Phenotype.
   bioRxiv [Preprint]. 2026 Jun 10:2026.06.08.729693.
   PubMed         Abstract available
   
   

   
   BMC Cardiovasc Disord

7. MA Y, Guo D, Wang J, Zhang X, et al
   Characteristics and prognostic significance of right atrium remodeling and tricuspid regurgitation after balloon pulmonary angioplasty-application value of echocardiography.
   BMC Cardiovasc Disord. 2026;26:532.
   PubMed         Abstract available
   
   

   
   BMC Med Imaging

8. XI Q, Gong J, Wang J, Guo X, et al
   Machine learning in CTEPH: predicting the efficacy of BPA based on clinical and echocardiographic features.
   BMC Med Imaging. 2025;25:328.
   PubMed         Abstract available
   
   

   
   BMC Nephrol

9. QIU L, Huang B, Liao Q, Li C, et al
   Severe pulmonary arterial hypertension development despite lupus nephritis remission: association with podocytic infolding glomerulopathy.
   BMC Nephrol. 2025;26:503.
   PubMed         Abstract available
   
   
10. YAGDIRAN B, Kirisci B, Uslu A, Cekmen N, et al
    Association of pretransplant pulmonary hypertension with posttransplant renal Doppler ultrasonography findings and biopsy-proven rejection.
    BMC Nephrol. 2026 Jun 25. doi: 10.1186/s12882-026-05156.
    PubMed         Abstract available
    
    

    
    BMC Pulm Med

11. MA J, Ren D, Zhen Y, Li A, et al
    Preoperative TAPSE/sPAP ratio predicts early residual pulmonary hypertension following pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.
    BMC Pulm Med. 2026 Jun 22. doi: 10.1186/s12890-026-04444.
    PubMed         Abstract available
    
    
12. FENG X, Hua M, Yang C, Zhu S, et al
    Clinical characteristic and prognosis of adult inpatients with high altitude pulmonary edema: a multi-central, retrospective study in plateau of China from 2012 to 2022.
    BMC Pulm Med. 2025;26:1.
    PubMed         Abstract available
    
    
13. TANAKA Y, Okamura K, Kaburaki S, Tanaka T, et al
    Evaluation of the impact of pulmonary circulation, particularly pulmonary vascular resistance, in patients with idiopathic pulmonary fibrosis: an exploratory study.
    BMC Pulm Med. 2025;25:407.
    PubMed         Abstract available
    
    

    
    Cardiol Discov

14. VANI S, Novarese F, Toma M, Porto I, et al
    Worldwide Epidemiology of Pulmonary Hypertension Associated With Left Heart Disease.
    Cardiol Discov. 2026;6:117-132.
    PubMed         Abstract available
    
    

    
    Cardiol Rev

15. TOBI Y, Buffer SW, Grullon G, Shlimon N, et al
    Pulmonary Hypertension and Kidney Disease: A Review of a High-Risk Patient Population.
    Cardiol Rev. 2026 Jun 24. doi: 10.1097/CRD.0000000000001381.
    PubMed         Abstract available
    
    

    
    Cardiovasc J Afr

16. GUNPATH C, Nadar A
    The effects of chronic administration of Cannabidiol and Cannabidiol-Selexipag combination on haematological parameters, oxidative stress, BNP, and TNF-alpha in a rat model of Pulmonary Arterial Hypertension.
    Cardiovasc J Afr. 2026;37:149-157.
    PubMed         Abstract available
    
    

    
    CJC Open

17. KARVASARSKI E, Park J, Savaris S, Beale A, et al
    Upfront Exercise Hemodynamic Phenotyping of Patients with Pulmonary Hypertension and Left Heart Disease Risk Factors: A Prospective Experience.
    CJC Open. 2026;8:757-765.
    PubMed         Abstract available
    
    

    
    Climacteric

18. HIPOLITO RODRIGUES MA, Gompel A
    Menopausal hormone therapy and pulmonary diseases.
    Climacteric. 2026;29:327-337.
    PubMed         Abstract available
    
    

    
    Clin Ter

19. NORONHA D, Mithra P P, Pai D N, L A, et al
    Sociodemographic determinants of Pulmonary Hypertension in a Tertiary Care Hospital in Southern India.
    Clin Ter. 2026;177:752-759.
    PubMed         Abstract available
    
    

    
    Commun Biol

20. ALHARBI R, Keles M, Fernandes N, Maude H, et al
    KLF6 activation marks an angiogenic and apoptosis resistant endothelial phenotype in pulmonary arterial hypertension.
    Commun Biol. 2026;9:846.
    PubMed         Abstract available
    
    

    
    EJNMMI Res

21. SEIGE LC, Heimer J, Murray K, Seiler E, et al
    Cardiopulmonary transit time measured on dynamic rubidium cardiac PET/CT is a predictor for pulmonary hypertension.
    EJNMMI Res. 2026 Jun 22. doi: 10.1186/s13550-026-01387.
    PubMed         Abstract available
    
    

    
    Eur J Appl Physiol

22. SOARES LL, Leite LB, Pelozin BRA, Costa SFF, et al
    Impact of ionic imbalances on rat cardiomyocyte function in pulmonary arterial hypertension: insights from energy dispersive X-ray spectroscopy and scanning electron microscopy analysis.
    Eur J Appl Physiol. 2026;126:3451-3459.
    PubMed         Abstract available
    
    

    
    Expert Rev Clin Pharmacol

23. AKAGI S, Kasahara S, Ejiri K, Nakamura K, et al
    Treatment strategies for pulmonary arterial hypertension associated with adult congenital heart diseases.
    Expert Rev Clin Pharmacol. 2026;19:559-566.
    PubMed         Abstract available
    
    

    
    Expert Rev Respir Med

24. EL-KERSH K, Shamsid-Deen N
    A profile on inhaled treprostinil for pulmonary hypertension.
    Expert Rev Respir Med. 2026 Jun 23. doi: 10.1080/17476348.2026.2694798.
    PubMed         Abstract available
    
    

    
    Front Immunol

25. GUO Q, Wu D, Zhang X, Yu L, et al
    Implications of systolic pulmonary artery pressure trajectories in systemic lupus erythematosus-associated pulmonary hypertension: a CSTAR-PAH cohort study.
    Front Immunol. 2026;17:1819805.
    PubMed         Abstract available
    
    

    
    Healthcare (Basel)

26. BEIS I, Dipla K, Boutou A, Zacharias A, et al
    Evolution of Exercise Training in Patients with Pulmonary Hypertension-A Comprehensive Review.
    Healthcare (Basel). 2026;14:1796.
    PubMed         Abstract available
    
    

    
    Indian Heart J

27. MANTOO MR, Majeed MW, Roy A
    Efficacy and safety of sotatercept in pulmonary arterial hypertension: A systematic review and meta-analysis of randomized controlled trials.
    Indian Heart J. 2026;78:144-150.
    PubMed         Abstract available
    
    

    
    Indian J Radiol Imaging

28. EAPEN KC, Mane M, Vimala LR, Sahu S, et al
    A Stepwise Approach to Computed Tomography Imaging of Pulmonary Hypertension.
    Indian J Radiol Imaging. 2025;36:300-315.
    PubMed         Abstract available
    
    

    
    Int J Cardiol Heart Vasc

29. KOMURA N, Sugano T, Suzuki T, Ono F, et al
    Retrospective evaluation of Selexipag monotherapy on pulmonary hemodynamics in newly diagnosed, treatment-naive patients with chronic thromboembolic pulmonary hypertension prior to balloon pulmonary angioplasty.
    Int J Cardiol Heart Vasc. 2026;65:101956.
    PubMed         Abstract available
    
    

    
    Int J Med Sci

30. DAI Q, Cai Y, Wang X, Li X, et al
    Lactate and Lactylation in Pulmonary Hypertension: Comprehensive Landscape and Future Perspectives.
    Int J Med Sci. 2026;23:2392-2407.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

31. MORALES-CANO D, Medrano-Garcia S, Barreira B, Hernandez-Garcia A, et al
    Pulmonary Immune Cell Landscape Altered by Exposure to HIV, Schistosoma and Their Combination.
    Int J Mol Sci. 2026;27:5426.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Dev Dis

32. YAMAN I, Korkmaz H, Akagac AE, Kaymaz T, et al
    ANO1 (TMEM16A) Genetic Variants, Promoter Methylation, and Chloride Dysregulation in Pulmonary Hypertension.
    J Cardiovasc Dev Dis. 2026;13:283.
    PubMed         Abstract available
    
    
33. CORIANO M, Pradegan N, Putorti F, Calonaci A, et al
    Risk Stratification of Adverse Outcomes After Heart Transplantation with the 2022 Definition of Pulmonary Hypertension.
    J Cardiovasc Dev Dis. 2026;13:227.
    PubMed         Abstract available
    
    

    
    J Clin Med

34. CROQUETTE M, Jutant EM, Larrieu-Ardilouze E, Trihan JE, et al
    Performances of Clinical, Biological and Echographic Signs to Assess Right Atrial Pressure in Pulmonary Hypertension.
    J Clin Med. 2026;15:4704.
    PubMed         Abstract available
    
    

    
    J Clin Rheumatol

35. KING M, Martinez A, Abbruzzese S, Fazzari M, et al
    Pulmonary Hypertension in Systemic Lupus Erythematosus Among Black and Hispanic Patients: An Observational Cohort Study.
    J Clin Rheumatol. 2026 Jun 16. doi: 10.1097/RHU.0000000000002381.
    PubMed         Abstract available
    
    

    
    J Mol Cell Cardiol

36. XU XH, Shen Y, Chen M, Miao YX, et al
    SnRNA-seq identifies FN1-SDC4 axis triggering epicardial activation in right ventricular remodeling in pulmonary hypertension.
    J Mol Cell Cardiol. 2026 Jun 26:S0022-2828(26)00096.
    PubMed         Abstract available
    
    

    
    J Nanobiotechnology

37. WANG G, Liu J, Bai P, Jiao H, et al
    Inhalable extracellular vesicle delivered IL-10 mRNA attenuates pulmonary hypertension in rats.
    J Nanobiotechnology. 2026 Jun 23. doi: 10.1186/s12951-026-04723.
    PubMed         Abstract available
    
    

    
    JACC Cardiovasc Imaging

38. GHIO S, Acquaro M
    Secondary Tricuspid Regurgitation in Pulmonary Hypertension: Marker, Mediator, and Potential Target?
    JACC Cardiovasc Imaging. 2026 Jun 19:S1936-878X(26)00270.
    PubMed        
    
    

    
    Med Sci (Basel)

39. MOHAMMED A, Hussein S, Mahdi G, Behnoush AH, et al
    The Utility of Extracorporeal Membrane Oxygenation in the Setting of Chronic Thromboembolic Pulmonary Hypertension.
    Med Sci (Basel). 2026;14:273.
    PubMed         Abstract available
    
    

    
    Medicina (B Aires)

40. BOSIO M, Baez M, Maldonado L, Salvado A, et al
    [Clinical and functional characteristics of patients with interstitial lung disease and pulmonary hypertension from a specialized lung disease center in Buenos Aires].
    Medicina (B Aires). 2026;86:726-732.
    PubMed         Abstract available
    
    

    
    Medicina (Kaunas)

41. ILIUTA L, Rac-Albu M, Rac-Albu ME, Andronesi A, et al
    Correction: Iliuta et al. Impact of Pulmonary Hypertension on Mortality After Surgery for Aortic Stenosis. Medicina 2022, 58, 1231.
    Medicina (Kaunas). 2026;62:1111.
    PubMed         Abstract available
    
    

    
    medRxiv

42. RISCHARD FP, Mendoza M, Insel M, Beck GJ, et al
    Resolving Diagnostic Discordance in Group 2 Pulmonary Hypertension Through Staged Physiologic Testing: Insights From PVDOMICS.
    medRxiv [Preprint]. 2026 Jun 10:2026.06.04.26354961.
    PubMed         Abstract available
    
    

    
    Paediatr Respir Rev

43. SALEY TP, Villafranco N, Griffiths M, Goss KN, et al
    Bronchopulmonary dysplasia associated pulmonary hypertension: implications across the lifespan.
    Paediatr Respir Rev. 2026 May 28:S1526-0542(26)00048.
    PubMed         Abstract available
    
    

    
    Pediatr Pulmonol

44. GUASTI E, Tardini G, Buratti S, Campone C, et al
    Alveolar Capillary Dysplasia With Misaligned Pulmonary Veins (ACDMPV): Description of Two Cases and Literature Review.
    Pediatr Pulmonol. 2026;61:e71704.
    PubMed         Abstract available
    
    

    
    PLoS One

45. NAKAHARA S, Hirao Y, Fujiuchi B, Matsuda B, et al
    Inhaled nitric oxide in fibrotic and advanced interstitial lung disease: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2026;21:e0351862.
    PubMed         Abstract available
    
    

    
    Pulm Circ

46. IGATA S, Tahara N, Tahara A, Honda A, et al
    Right Ventricular Mechanical Dyssynchrony Reflects Hemodynamic Load in Pre-Capillary Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70343.
    PubMed         Abstract available
    
    

    
    Respir Investig

47. SHIMA H, Sato T, Tsujino I, Yoshikawa S, et al
    Efficacy of short-term, low-dose pulmonary vasodilators for chronic thromboembolic pulmonary hypertension: a retrospective pilot study.
    Respir Investig. 2026;64:101473.
    PubMed         Abstract available
    
    

    
    Respir Med

48. DURDU H, Merc P, Cinar B, Gunaydin ZY, et al
    Can AI chatbots effectively respond inquiries for patients with pulmonary arterial hypertension about exercise and physical activity: A comparative study of three chatbots.
    Respir Med. 2026;260:108948.
    PubMed         Abstract available
    
    

    
    Respir Res

49. ZHANG J, Liu J, Chen Y, Chen H, et al
    Activation of PBK by Gal-3 contributes to pulmonary artery hypertension by promoting PRC1 activation.
    Respir Res. 2026;27:65.
    PubMed         Abstract available
    
    
50. SAINT-MARTIN WILLER A, Masson B, Laubry L, Dutheil M, et al
    TRPC channels contribute to endothelial dysfunction in pulmonary arterial hypertension.
    Respir Res. 2025;26:345.
    PubMed         Abstract available
    
    

    
    Rev Med Interne

51. BARILE R, Rotondo C, Giancaspro G, Rella V, et al
    Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.
    Rev Med Interne. 2026 Jun 22:S0248-8663(26)00630.
    PubMed         Abstract available
    
    

    
    SAGE Open Med

52. ZHANG Z, Gu T, Xu H, Zhang Y, et al
    Invasive versus non-invasive management in non-ST segment elevation myocardial infarction patients with pulmonary hypertension.
    SAGE Open Med. 2026;14:20503121261449544.
    PubMed         Abstract available
    
    

    
    Sci Prog

53. HE H, Liu Z, Yu Q, Fu Q, et al
    Genetically predicted serum uric acid and pulmonary arterial hypertension: Mendelian randomization with an exploratory NHANES risk-burden analysis.
    Sci Prog. 2026;109:368504261463441.
    PubMed         Abstract available
    
    

    
    Toxicol Sci

54. CHAROENPONG P, Hall NM, Keller CM, Kumar A, et al
    Pulmonary vascular remodeling in rats following methamphetamine self-administration: toward a model of methamphetamine-associated pulmonary arterial hypertension.
    Toxicol Sci. 2026;209:kfag072.
    PubMed         Abstract available
    
    

    
    Transl Vis Sci Technol

55. BISEN JB, Sikora H, Shah R, Drakopoulos M, et al
    Retinal Ischemic Perivascular Lesions in Pulmonary Hypertension: Retinal Biomarkers Informing Systemic Microvascular Dysfunction.
    Transl Vis Sci Technol. 2026;15:28.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum